Author

Marie L. Woolley

Observed names: M. L. Woolley, M.L Woolley, M.L. Woolley, MARIE L WOOLLEY, ML Woolley, Marie L Woolley, Marie Woolley

Institution: GlaxoSmithKline (United Kingdom)

Observed institutions: F. Hoffmann-La Roche AG, University of Nottingham, GlaxoSmithKline (United Kingdom), Eli Lilly (United Kingdom), Queen's Medical Centre, GlaxoSmithKline Research & Development Limited (United Kingdom), Case Western Reserve University

OpenAlex ID: A5111746838

5-ht6 Receptors

2004 · Marie Woolley, Charles Marsden, et al. · CNS & Neurological Disorders - Drug Targets · 302

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

2007 · Andrew D. Medhurst, Alan R. Atkins, et al. · Journal of Pharmacology and Experimental Therapeutics · 301

A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze

2001 · M.L Woolley, J.C Bentley, et al. · Neuropharmacology · 206

5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation—an effect sensitive to NMDA receptor antagonism

2004 · M.V King, A.J Sleight, et al. · Neuropharmacology · 198

Activity of 2,3-benzodiazepines at Native Rat and Recombinant Human Glutamate Receptors In Vitro : Stereospecificity and Selectivity Profiles

1996 · DAVID BLEAKMAN, BARBARA A BALLYK, et al. · Neuropharmacology · 191

The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity

2007 · M. L. Woolley, D. J. Pemberton, et al. · Psychopharmacology · 189

Age-dependent cognitive decline and amygdala pathology in α-synuclein transgenic mice

2006 · Christian Freichel, Manuela Neumann, et al. · Neurobiology of Aging · 174

Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro�04-6790

2003 · Marie L. Woolley, Charles A. Marsden, et al. · Psychopharmacology · 125

Isolation rearing impairs novel object recognition and attentional set shifting performance in female rats

2008 · SL McLean, B. Grayson, et al. · Journal of Psychopharmacology · 118

PDF

The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison

2005 · Theresa M. Ballard, Marie L. Woolley, et al. · Psychopharmacology · 110

Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice

2008 · Marie L. Woolley, Helen J. Carter, et al. · European Journal of Pharmacology · 98

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

2008 · Samantha L. McLean, Jonathan P. Beck, et al. · Behavioural Brain Research · 89

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat

2009 · Samantha L. McLean, Marie L. Woolley, et al. · Psychopharmacology · 68

PDF

Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR

2009 · Anne-Cécile Fricker, M.H. Selina Mok, et al. · Neuropharmacology · 67

D1-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia

2009 · Samantha L. McLean, Nagi F. Idris, et al. · European Neuropsychopharmacology · 67

Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat

2008 · Marie L. Woolley, Kerry A. Waters, et al. · Behavioural Pharmacology · 58

Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040

2008 · Eric Southam, Jackie Cilia, et al. · Psychopharmacology · 54

Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat

2008 · M. L. Woolley, K. A. Waters, et al. · Psychopharmacology · 49

Effects of subchronic phencyclidine on behaviour of female rats on the elevated plus maze and open field

2009 · SL McLean, ML Woolley, et al. · Journal of Psychopharmacology · 21

2005 · M.L. Woolley, T.M. Ballard · Behavioural Brain Research · 17

Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile

2019 · Simon E Ward, Mark H Harries, et al. · Journal of Psychopharmacology · 16

PDF

Pharmacological characterization ofN‐[(2S)‐5‐(6‐fluoro‐3‐pyridinyl)‐2, 3‐dihydro‐1H‐inden‐2‐yl]‐2‐propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator

2016 · Simon E Ward, Paul Beswick, et al. · British Journal of Pharmacology · 13

PDF

Investigating the effect of bilateral amygdala lesions on fear conditioning and social interaction in the male Mongolian gerbil

2006 · M.L. Woolley, M. Haman, et al. · Brain Research · 13

BACE/APPV717F Double-Transgenic Mice Develop Cerebral Amyloidosis and Inflammation

2005 · Laurence Ozmen, Marie Woolley, et al. · Neurodegenerative Diseases · 11

5-HT6 Receptors as Targets for the Treatment of Cognitive Deficits in Schizophrenia

2006 · Rudy Schreiber, Andrew Sleight, et al. · The Receptors · 7

Works count: 33

Citation count: 2,564

H-index: 19

I10-index: 24